The advanced glycation end product N(epsilon)-carboxymethyllysine is not a predictor of cardiovascular events and renal outcomes in patients with type 2 diabetic kidney disease and hypertension.
暂无分享,去创建一个
L. Hunsicker | G. Wolf | U. Ott | S. Franke | M. Busch | A. Brandstädt | J. Gerth | G. Stein